Testing MT1002 for heart attack patients getting a stent
Part of Heart & circulation clinical trials.
This study tests an investigational medicine called MT1002 in people who have had a heart attack and are about to get a stent (PCI). The goal is to see if MT1002 helps prevent further heart problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 85 years old.
- You have been diagnosed with acute coronary syndrome (a type of heart attack or unstable angina).
- You are scheduled for a procedure called PCI (angioplasty with stenting) during this hospital stay.
- You do not have recent or active bleeding problems, strokes, or other serious health conditions.
- Your weight is at least 110 pounds (men) or 99 pounds (women), and your BMI is between 18 and 30.
- You agree to use effective birth control if needed (for women able to have children and men with partners who can).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two types of stents that release medicine to help keep arteries open after an acute coronary syndrome event (often called a heart attack or unstable angina). It tests whether the standard short course of two blood-thinning medicines for one month is enough, and which stent strategy works best.
This trial tests whether implanting stents in non-obstructive, high-risk plaques (thin-capped fatty plaques) can prevent future heart attacks. It is for people who have already had treatment for a recent heart attack or unstable angina and have additional plaques that are not severely blocking blood flow but are vulnerable.
This trial tests whether a low-dose clot-busting medicine placed into the heart artery after a primary stent can improve outcomes in people with a certain type of heart attack. It also involves short hospital follow-ups and a heart MRI to look at how the heart is recovering.
This study tests an investigational drug called SGC001 for people having a heart attack affecting the front wall of the heart. The goal is to see if adding this drug to the standard artery-opening procedure helps improve outcomes.
This trial tests a new medicine called RTP-026 for people having a serious heart attack (STEMI). It looks at whether the medicine is safe and helps the heart recover better when given along with the standard procedure to open the blocked artery.
This trial uses special imaging (OCT or IVUS) to look at other blockages in your heart arteries that weren't treated during your stent procedure. It helps doctors decide if those blockages might need treatment later.
Hear when a new Acute Coronary Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.